Skip to main content
. 2022 Dec 9;12(6):2202412. doi: 10.1002/adhm.202202412

Figure 3.

Figure 3

QTPlus‐AM21 inhibits A549 cell growth in vitro. A) Colony formation assay of A549 cells treated with AM21 (0, 1, and 10 um) in free solution and QTPlus formulation for 1 week. B) The percentage of colony formation was determined by UV–vis spectrometry at 540 nm (crystal violet). C) Cell viability assay of A549 cells treated with erlotinib single treatment (0, 3.13, 6.25, 12.5, 25, 50, 100, 200 µm), QTPlus‐AM21 single treatment (0, 100, 200, 400, 800, 1600, 3200, 6400 nm) or in combination with QTPlus‐AM21 with a fixed concentration ratio (QTPlus AM21/erlotinib of 6.4/200) for 72 h (n = 3).